Author

Daniel Kofi Nyame

Institution: China Pharmaceutical University

Observed institution: China Pharmaceutical University

ORCID: 0009-0004-8209-2478

Observed ORCID: 0009-0004-8209-2478

OpenAlex ID: A5122395829

Innovative immunotherapies for prostate cancer: understanding the synergies between checkpoint inhibition, CAR T-cell therapy, and next-generation therapeutic modalities

2026 · Daniel Kofi Nyame, Vongai Baye, et al. · Exploration of Drug Science · 1

Knowledge, awareness, and practices of adverse drug reaction reporting among healthcare professionals in the Ashanti region of Ghana

2026 · Emmanuel Delali Kofi Fiagbey, Linda Nyame, et al. · Indian Journal of Pharmacology

Gasdermin D: a key mediator of inflammation in cardiovascular disease with a focus on atherosclerosis

2026 · Hajara Babie Musa, Daniel Kofi Nyame, et al. · Exploration of Cardiology

Prediction of low cardiac output syndrome in patients following non-isolated coronary artery bypass grafting surgery using machine learning

2026 · Emmanuel Delali Kofi Fiagbey, Jiawen Wang, et al. · Exploration of Cardiology

The autophagy-exosome axis in chronic prostatitis/chronic pelvic pain syndrome: a hypothesis-driven narrative review

2026 · Daniel Kofi Nyame, Francis Goku, et al. · Exploration of Immunology

The exosome-autophagy axis: emerging mechanisms and therapeutic implications in type III prostatitis

2026 · Daniel Kofi Nyame, Xiaohui Zhou · World Journal of Urology

Works count: 6

Citation count: 1

H-index: 1

I10-index: